Digital Content 
NEWS #PharmaBuzz
14 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/14/3081112/0/en/PharmaTher-Unveils-KetaVault-A-First-of-Its-Kind-Portal-to-Accelerate-Ketamine-Research-and-Commercialization.html
14 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/alar-pharmaceuticals-announces-first-patient-dosing-in-a-study-of-ala-3000-extended-release-ketamine-injection-for-treatment-resistant-depression-trd-302454659.html
05 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-inc-nasdaqnrxp-files-patent-application-for-nrx-100-its-proprietary-preservative-free-formulation-of-iv-ketamine-302445755.html
30 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/30/3071310/0/en/Silo-Pharma-s-SP-26-Ketamine-Implant-Meets-All-Endpoints-in-Fibromyalgia-Study.html
16 Apr 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/mira-pharmaceuticals-announces-positive-results-for-ketamir-2-in-diab-1015232
03 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/tasman-therapeutics-advancing-oral-ketamine-program-to-pivotal-phase-3-studies-302419722.html
Share 